Literature DB >> 8649443

Selection of peptides that bind to the HLA-A2.1 molecule by molecular modelling.

J S Lim1, S Kim, H G Lee, K Y Lee, T J Kwon, K Kim.   

Abstract

Cytotoxic T lymphocytes recognize antigenic peptides in association with major histocompatibility complex class I proteins. Although a large set of class I binding peptides has been described, it is not yet easy to search for potentially antigenic peptides without synthesis of a panel of peptides, and subsequent binding assays. In order to predict HLA-A2.1-restricted antigenic epitopes, a computer model of the HLA-A2.1 molecule was established using X-ray crystallography data. In this model nonameric peptide sequences were aligned. In a molecular dynamics (MD) simulation with two sets of peptides known to be presented by HLA-A2.1, it was important to know the anchor amino acid residue preference and the distance between the anchor residues. We show here that the peptides bound to the HLA-A2.1 model structure possess a side chain of C-terminal anchor residue oriented into the binding groove with different distances between the two anchor residues from 15 to 21A. We also synthesized a set of nonamer peptides containing amino acid sequences of Hepatitis B virus protein that were selected on the basis of previously described HLA-A2.1 specific motifs. When results obtained from the MD simulation were compared with functional binding assays using the TAP-deficient cell line T2, it was evident that the MD simulation method improves prediction of the HLA-A2.1 binding epitope sequence. These results suggest that this approach can provide a way to predict peptide epitopes and search for antigenic regions in sequences in a variety of antigens without screening a large number of synthetic peptides.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8649443     DOI: 10.1016/0161-5890(95)00065-8

Source DB:  PubMed          Journal:  Mol Immunol        ISSN: 0161-5890            Impact factor:   4.407


  11 in total

1.  Predicting sequences and structures of MHC-binding peptides: a computational combinatorial approach.

Authors:  J Zen; H R Treutlein; G B Rudy
Journal:  J Comput Aided Mol Des       Date:  2001-06       Impact factor: 3.686

2.  Modeling the structure of bound peptide ligands to major histocompatibility complex.

Authors:  Joo Chuan Tong; Tin Wee Tan; Shoba Ranganathan
Journal:  Protein Sci       Date:  2004-09       Impact factor: 6.725

3.  Novel myeloma-associated antigens revealed in the context of syngeneic hematopoietic stem cell transplantation.

Authors:  Melinda A Biernacki; Yu-tzu Tai; Guang Lan Zhang; Anselmo Alonso; Wandi Zhang; Rao Prabhala; Li Zhang; Nikhil Munshi; Donna Neuberg; Robert J Soiffer; Jerome Ritz; Edwin P Alyea; Vladimir Brusic; Kenneth C Anderson; Catherine J Wu
Journal:  Blood       Date:  2012-01-20       Impact factor: 22.113

4.  Computational prediction and experimental assessment of an HLA-A*0201-restricted cytotoxic T lymphocyte epitope from neutral endopeptidase.

Authors:  Jingbo Zhang; Zhengcai Jia; Zhihua Lin; Jingyi Li; Xiaolan Fu; Yunjian Huang; Jinghong Zhao; Ling Nie; Weiping Hou; Fahuan Yuan; Yuzhang Wu
Journal:  Immunol Res       Date:  2012-06       Impact factor: 2.829

5.  Identification of HLA-A*0201-restricted cytotoxic T lymphocyte epitope from proliferating cell nuclear antigen.

Authors:  Wei Xu; Hui-Zhong Li; Jun-Jie Liu; Zhen Guo; Bao-Fu Zhang; Fei-Fei Chen; Dong-Sheng Pei; Jun-Nian Zheng
Journal:  Tumour Biol       Date:  2010-08-16

6.  Proteomics in Vaccinology and Immunobiology: An Informatics Perspective of the Immunone.

Authors:  Irini A. Doytchinova; Paul Taylor; Darren R. Flower
Journal:  J Biomed Biotechnol       Date:  2003

7.  T-cell epitope prediction and immune complex simulation using molecular dynamics: state of the art and persisting challenges.

Authors:  Matthew N Davies; Darren R Flower; Kanchan Phadwal; Isabel K Macdonald; Peter V Coveney; Shunzhou Wan
Journal:  Immunome Res       Date:  2010-11-03

8.  HLA-A2-restricted cytotoxic T lymphocyte epitopes from human heparanase as novel targets for broad-spectrum tumor immunotherapy.

Authors:  Ting Chen; Xu-Dong Tang; Yin Wan; Ling Chen; Song-Tao Yu; Zhen Xiong; Dian-Chun Fang; Guang-Ping Liang; Shi-Ming Yang
Journal:  Neoplasia       Date:  2008-09       Impact factor: 5.715

9.  Predicting HLA class I non-permissive amino acid residues substitutions.

Authors:  T Andrew Binkowski; Susana R Marino; Andrzej Joachimiak
Journal:  PLoS One       Date:  2012-08-08       Impact factor: 3.240

Review 10.  T-cell epitope vaccine design by immunoinformatics.

Authors:  Atanas Patronov; Irini Doytchinova
Journal:  Open Biol       Date:  2013-01-08       Impact factor: 6.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.